Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 1
Submit an article Journal homepage
270
Views
6
CrossRef citations to date
0
Altmetric
Articles

Comparison of the efficacy of Tacrolimus 0.1% ointment and Tacrolimus 0.1% plus topical pseudocatalase/superoxide dismutase gel in children with limited vitiligo: a randomized controlled trial

Diala M. Alshiyaba Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0244-0221View further author information
ORCID Icon,
Firas A. Al-qarqaza Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanORCID Iconhttps://orcid.org/0000-0003-4876-7406View further author information
ORCID Icon,
Jihan M. Muhaidata Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanORCID Iconhttps://orcid.org/0000-0002-0365-6940View further author information
ORCID Icon,
Yousef S. Alkhaderb Department of Public Health, Community Medicine, Jordan University of Science and Technology, Irbid, JordanORCID Iconhttps://orcid.org/0000-0002-7830-6857View further author information
ORCID Icon,
Ruba F. Al-sheyaba Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanView further author information
&
Sala I. Jafaara Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanView further author information
Pages 146-149 | Received 24 Jan 2020, Accepted 08 Feb 2020, Published online: 21 Feb 2020

References

  • Yaghoobi R, Omidian M, Bagherani N. Vitiligo: a review of the published work. J Dermatol. 2011;38(5):419–431.
  • Mohammed GF. Highlights in pathogenesis of vitiligo. World J Clin Cases. 2015;3(3):221.
  • Amer AAA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608–614.
  • Whitton M, Pinart M, Batchelor JM, et al. Evidence-based management of vitiligo: summary of a Cochrane systematic review. Br J Dermatol. 2016;174(5):962–969.
  • Faria AR, Mira MT, Tarlé RG, et al. Vitiligo - part 2 - classification, histopathology and treatment. An Bras Dermatol. 2014;89(5):784–790.
  • Laddha NC, Dwivedi M, Mansuri MS, et al. Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol. 2013;22(4):245–250.
  • Arican O, Kurutas EB. Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerol Alp Pannonica Adriat. 2008;17(1):12–16.
  • Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol. 1991;97(6):1081–1085.
  • Schallreuter KU, Moore J, Wood JM, et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Invest Dermatol Symp Proc. 1999;4(1):91–96.
  • Rokos H, Beazley WD, Schallreuter KU. Oxidative stress in vitiligo: photo-oxidation of pterins produces H2O2 and pterin-6-carboxylic acid. Biochem Biophys Res Commun. 2002;292(4):805–811.
  • Sanclemente G, Garcia JJ, Zuleta JJ, et al. Double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo. J Eur Acad Dermatol Venereol. 2008;22(11):1359–1364.
  • Schallreuter KU, Wood JM, Lemke KR, et al. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology. 1995;190(3):223–229.
  • Kostović K, Paštar Z, Pašic A, et al. Treatment of vitiligo with narrow-band UVB and topical gel containing catalase and superoxide dismutase. Acta Dermatovenerol Croat. 2007;15(1):10–14.
  • Yuksel EP, Aydin F, Senturk N, et al. Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients. Eur J Dermatol. 2009;19(4):341–344.
  • Fatemi-Naeini F, Vaez-Shooshtari A, Ebrahimi B, et al. The effect of pseudocatalase/superoxide dismutase in treatment of vitiligo: a pilot study. J Isfahan Med Sch. 2014;31(269):2309–2314.
  • Paracha MM, Khurshid K, Pal SS, et al. Comparison of treatment with tacrolimus 0.03% and superoxide dismutase and catalase in vitiligo. J Postgr Med Inst. 2010;24(2):115–121.
  • Schallreuter KU. Successful treatment of oxidative stress in vitiligo. Skin Pharmacol Physiol. 1999;12(3):132–138.
  • Alshiyab DM, Al-Qarqaz FA, Heis LH, et al. Assessment of serum vitamin D levels in patients with vitiligo in Jordan: a case-control study. Dermatol Res Pract. 2019;2019:1–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.